Search research articles
Contact Us
Filters
Showing results (981-990 of 1,110) with videos related to
Page
of 111
Sort By:
Annals of Surgical Oncology
|
March 27, 2019
False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma
Amanda A G Nijhuis, Mbathio Dieng, Nikita Khanna, et al.
Annals of Surgery
|
October 8, 2003
Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases
Donald L Morton, Dave S B Hoon, Alistair J Cochran, et al.
Pediatric Blood & Cancer
|
June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program
Richard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Open Forum Infectious Diseases
|
August 8, 2022
Notifiable Infectious Diseases Among Organ Transplant Recipients: A Data-Linked Cohort Study, 2000-2015
Karen M J Waller, Nicole L De La Mata, Kate R Wyburn, et al.
Pediatric Blood & Cancer
|
January 22, 2013
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
Stephen T Keir, John M Maris, C Patrick Reynolds, et al.
Annals of Surgery
|
October 16, 1999
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group
D L Morton, J F Thompson, R Essner, et al.
Immunotherapy
|
May 3, 2023
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy
Jake R Thompson, Julia Lai-Kwon, Rachael L Morton, et al.
Pediatric Blood & Cancer
|
February 9, 2012
Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing program
Richard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 17, 2010
Indole- and benzothiophene-based histamine H3 antagonists
Alejandro Santillan, Kelly J McClure, Brett D Allison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2016
Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
Suhendan Ekmekcioglu, Michael A Davies, Keiji Tanese, et al.
Page
of 111
Search research articles
Search
Showing results (981-990 of 1,110) with videos related to
Sort By:
Page
of 111
Annals of Surgical Oncology
|
March 27, 2019
False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma
Amanda A G Nijhuis, Mbathio Dieng, Nikita Khanna, et al.
Annals of Surgery
|
October 8, 2003
Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases
Donald L Morton, Dave S B Hoon, Alistair J Cochran, et al.
Pediatric Blood & Cancer
|
June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program
Richard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Open Forum Infectious Diseases
|
August 8, 2022
Notifiable Infectious Diseases Among Organ Transplant Recipients: A Data-Linked Cohort Study, 2000-2015
Karen M J Waller, Nicole L De La Mata, Kate R Wyburn, et al.
Pediatric Blood & Cancer
|
January 22, 2013
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program
Stephen T Keir, John M Maris, C Patrick Reynolds, et al.
Annals of Surgery
|
October 16, 1999
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group
D L Morton, J F Thompson, R Essner, et al.
Immunotherapy
|
May 3, 2023
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy
Jake R Thompson, Julia Lai-Kwon, Rachael L Morton, et al.
Pediatric Blood & Cancer
|
February 9, 2012
Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing program
Richard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 17, 2010
Indole- and benzothiophene-based histamine H3 antagonists
Alejandro Santillan, Kelly J McClure, Brett D Allison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2016
Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
Suhendan Ekmekcioglu, Michael A Davies, Keiji Tanese, et al.
Page
of 111